Literature DB >> 10660125

Selective binding of the truncated form of the chemokine CKbeta8 (25-99) to CC chemokine receptor 1(CCR1).

T A Berkhout1, J Gohil, P Gonzalez, C L Nicols, K E Moores, C H Macphee, J R White, P H Groot.   

Abstract

Human CC chemokine receptor 1 (CCR1) has been proposed as a receptor for CKbeta8. To obtain conclusive evidence, binding-displacement studies of 125I-CKbeta8 (25-99) were performed on membranes of Chinese hamster ovary cells expressing human CCR1. The Ic50 for displacement of 125I-CKbeta8 (25-99) with CKbeta8 (25-99) was 0.22 nM. The longer forms of CKbeta8 (24-99 and 1-99) also displaced 125I-CKbeta8, with Ic50 values of 6.5 and 16 nM, respectively. Displacement profiles of 125I-CKbeta8 (25-99) on freshly prepared human monocytes indicated that CCR1 was the major receptor for CKbeta8. We conclude that CCR1 is a receptor for different-length CKbeta8 and that CKbeta8 (25-99) has a similar affinity for CCR1 as macrophage inflammatory protein-1alpha (MIP-1alpha). The longer variants of CKbeta8 are significantly less potent than CKbeta8 (25-99) and MIP-1a on CCR1 and monocytes (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660125     DOI: 10.1016/s0006-2952(99)00354-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

Review 1.  Chemokines in tumor angiogenesis and metastasis.

Authors:  Seema Singh; Anguraj Sadanandam; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

2.  Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta.

Authors:  Chuan-Chu Chou; Jay S Fine; Catherine Pugliese-Sivo; Waldemar Gonsiorek; Liza Davies; Gregory Deno; Mary Petro; Martin Schwarz; Paul J Zavodny; R William Hipkin
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  α1B/D-adrenoceptors regulate chemokine receptor-mediated leukocyte migration via formation of heteromeric receptor complexes.

Authors:  Garrett A Enten; Xianlong Gao; Hannah R Strzelinski; McWayne Weche; Stephen B Liggett; Matthias Majetschak
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-10       Impact factor: 12.779

4.  A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor.

Authors:  Aram Elagoz; Duncan Henderson; Poda Suresh Babu; Sylvia Salter; Caroline Grahames; Lorna Bowers; Marie-Odile Roy; Patricia Laplante; Eric Grazzini; Sultan Ahmad; Paola M C Lembo
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

5.  Tissue proteases convert CCL23 into potent monocyte chemoattractants in patients with chronic rhinosinusitis.

Authors:  Julie A Poposki; Anjeni Keswani; Julie K Kim; Aiko I Klingler; Lydia A Suh; James Norton; Roderick G Carter; Anju T Peters; Kathryn E Hulse; Leslie C Grammer; Bruce K Tan; David B Conley; Juan C Jaen; Thomas J Schall; Robert C Kern; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2015-11-10       Impact factor: 10.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.